WILMINGTON, DE - Enovis (NYSE: ENOV), a prominent medical technology company with a market capitalization of $2.54 billion, has announced the appointment of Davide Visentin as the new President of ...

Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...

$40,000 of ENOVIS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Medicare DME Competitive Bidding reforms and ...

Enovis (ENOV), a global medical technology company, Friday, announced that Davide Visentin will take over as President of Enovis ...

Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical ...

GET MORE AI-GENERATED SIGNALS: January 21, 2025, 17:54 pm ET, BY THOMAS KEE- Contributor| Editor: Thomas H. Kee Jr. ( Follow on LinkedIn) Check the time stamp on this data. Updated AI-Generated ...

Oak Thistle LLC acquired a new position in shares of Enovis Co. (NYSE:ENOV – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission ...

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr. Benjamin ...

Enovis has named Davide Visentin as its new president of the international surgical business, according to a Jan. 17 report from Mass Device. Mr. Visentin will succeed Benjamin Reinmann, MD, beginning ...

Check the time stamp on this data. Updated AI-Generated Signals for Enovis Corporation (ENOV) available here: ENOV. Type a ...

Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr ...